Stay updated on BION-1301 Study in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the BION-1301 Study in IgA Nephropathy Clinical Trial page.

Latest updates to the BION-1301 Study in IgA Nephropathy Clinical Trial page
- CheckyesterdayChange DetectedDifference0.1%
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.8%
- Check37 days agoChange DetectedThe study has expanded from 157 to 181 locations, with several new recruiting sites added in Canada, China, India, Italy, Japan, and Spain. Additionally, the study has been updated to reflect changes in eligibility criteria and the principal investigator has been removed.SummaryDifference11%
- Check44 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.9%
- Check51 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.4%
- Check58 days agoChange DetectedDifference0.4%
Stay in the know with updates to BION-1301 Study in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BION-1301 Study in IgA Nephropathy Clinical Trial page.